BD Nano 2nd Gen Pen Needles

Redesigned with patients in mind

BD Nano 2nd Gen Pen Needles help reduce the potential consequences of user injection force variability, providing a more reliable subcutaneous injection depth and reducing the risk of intramuscular injections. Additionally, the new ergonomic design provides an easier and more comfortable injection experience.1,2

Wider outer cover

Easier to attach to pen device1

Larger, green, inner needle shield

Easier to grip and remove before an injection1

Contoured needle base

Provides greater comfort and is designed to compensate for injection force variability, supporting more reliable subcutaneous injections1,2


More reliable subcutaneous injections across a range of injection forces, with an up to ~8x reduction in the risk of intramuscular injection vs other 4mm pen needles2,*


Easier and more comfortable injections from start to finish.1


Supports patient confidence with the injection experience1


Compatible with widely used pen injector devices3

BD PentaPoint Comfort and EasyFlow Technology

Existing proven benefits of BD PentaPoint Comfort and EasyFlow Technology 4,5


* Across recommended injection sites: abdomen, thigh, arm, buttock, pooled across gender and BMI

  1. Whooley S, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
  2. Rini C, et al. Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection.J Diabetes Sci Technol. 2019;13(3):533-545.
  3. BD Compatibility Confirmation for Pen Needles and Pen Injector Manufacturers; Document Number: 149OTH-0004-20 Rev K Dated: 10 April 2019.
  4. Hirsch L.,et al. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes. Journal of Diabetes Science and Technology. 2012;6(2):328-335
  5. Aronson R et al. Insulin pen needles: Effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clinical Therapeutics. 2013;35(7):923-933.